| P2093 | author name string | Ramdas G Pai | |
| | Hoda Butrous | |
| P2860 | cites work | Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study | Q48570168 |
| | Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study | Q48795012 |
| | Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. | Q53551017 |
| | Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. | Q53578883 |
| | 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Q28239484 |
| | Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). | Q34383304 |
| | New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment | Q34577241 |
| | Irbesartan in patients with heart failure and preserved ejection fraction | Q34877640 |
| | Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic | Q35040738 |
| | Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications. | Q35535837 |
| | Use and Limitations of E/e' to Assess Left Ventricular Filling Pressure by Echocardiography | Q35676084 |
| | Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol | Q35922161 |
| | Role of angiotensin II in the evolution of diastolic heart failure | Q36332211 |
| | Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. | Q36371015 |
| | Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry | Q36441592 |
| | Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy | Q36701220 |
| | Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction | Q36769919 |
| | Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial | Q37328507 |
| | Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. | Q37387706 |
| | The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis | Q37703764 |
| | Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function. | Q37824789 |
| | Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure | Q37972136 |
| | Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial | Q38455453 |
| | How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology | Q40224176 |
| | Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure | Q40848691 |
| | Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle | Q41265653 |
| | Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure | Q43119762 |
| | Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients | Q44009234 |
| | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Q44588075 |
| | Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction | Q44723488 |
| | Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis | Q45020454 |
| P433 | issue | 9 | |
| P921 | main subject | ejection fraction | Q641303 |
| P304 | page(s) | 1179-1193 | |
| P577 | publication date | 2013-08-23 | |
| P1433 | published in | Expert Review of Cardiovascular Therapy | Q15733727 |
| P1476 | title | Heart failure with normal ejection fraction: current diagnostic and management strategies | |
| P478 | volume | 11 | |